Medical Research Charities is proud to have The Scripps Research Institute as one of our 24 superstar member charities dedicated to researching cures for life’s most dreaded diseases. Standing at the forefront of basic biomedical science, a vital segment of research that seeks to comprehend the most fundamental processes of health and disease, The Scripps Research Institute is one of the world’s largest private non-profit medical research organizations.
The National Institutes of Health is giving a La Jolla scientist a record $120 million to help medicine make a historic shift to treating patients based on their specific genetic makeup, lifestyle and environment.
Dr. Eric Topol will co-lead the effort to enroll and engage 1 million Americans in a study that will deeply explore people’s health and regularly provide them with information that they can share with their doctors.
The $120 million is believed to be the largest single grant the NIH has ever awarded to a San Diego scientist. It is part of the Obama administration’s Precision Medicine Initiative, which will customize patient care through big advances in digital technology.
Topol is one of the nation’s best known digital medicine advocates. The Scripps Research Institute professor has been pushing medicine to use mobile sensors and smartphone apps to monitor and treat patients. He’s also pushed doctors to tie treatment to a broader range of data, ranging from a person’s genome to their diet to the air quality in their neighborhood and the microbes in their gut.
Topol’s interests are reflected in the NIH’s new all-volunteer study, which will last at least five years. People will use mobile and web apps to register and participate. The “citizen scientists” will be able to upload a wide variety of data, including blood pressure, heart rhythm, glucose levels and sleep and exercise patterns. The app also can upload recordings of the tremors that are experienced by patients with Parkinson’s disease.
Click here to read the full article by Gary Robbins, The San Diego Union Tribune.